FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

29883711000001102: Lansoprazole 15mg orodispersible tablets (Sigma Pharmaceuticals Plc) 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Jul 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
93096901000001119 Lansoprazole 15mg orodispersible tablets (Sigma Pharmaceuticals Plc) 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
93097001000001115 Lansoprazole 15mg orodispersible tablets (Sigma Pharmaceuticals Plc) 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lansoprazole 15mg orodispersible tablets (Sigma Pharmaceuticals Plc) 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Sigma Pharmaceuticals Plc) 28 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Sigma Pharmaceuticals Plc) 28 tablet Is a Lansoprazole 15mg orodispersible gastro-resistant tablets 28 tablet true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Sigma Pharmaceuticals Plc) 28 tablet Has AMP Lansoprazole 15mg orodispersible tablets (Sigma Pharmaceuticals Plc) true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Sigma Pharmaceuticals Plc) 28 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Sigma Pharmaceuticals Plc) 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Sigma Pharmaceuticals Plc) 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Sigma Pharmaceuticals Plc) 28 tablet Has specific active ingredient Lansoprazole true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Sigma Pharmaceuticals Plc) 28 tablet Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Sigma Pharmaceuticals Plc) 28 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Sigma Pharmaceuticals Plc) 28 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Sigma Pharmaceuticals Plc) 28 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start